These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vitamin D and Probability of Developmental Disorders among Perinatally HIV-Affected and Unaffected Ugandan Children. Awadu JE, Giordani B, Sikorskii A, Abbo C, Fenton JI, Zalwango S, Ezeamama AE. Nutrients; 2023 Apr 22; 15(9):. PubMed ID: 37432158 [Abstract] [Full Text] [Related]
6. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS, Dokubo EK, Sint TT. Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370 [Abstract] [Full Text] [Related]
8. Serum Vitamin D is Differentially Associated with Socioemotional Adjustment in Early School-Aged Ugandan Children According to Perinatal HIV Status and In Utero/Peripartum Antiretroviral Exposure History. Yakah W, Fenton JI, Sikorskii A, Zalwango SK, Tuke R, Musoke P, Boivin MJ, Giordani B, Ezeamama AE. Nutrients; 2019 Jul 12; 11(7):. PubMed ID: 31336843 [Abstract] [Full Text] [Related]
10. Neurodevelopment of children who are HIV-exposed and uninfected in Kenya. Bulterys MA, Njuguna I, King'e M, Chebet D, Moraa H, Gomez L, Onyango A, Malavi K, Nzia G, Chege M, Neary J, Wagner AD, Lawley KA, Wamalwa D, Benki-Nugent S, John-Stewart G. J Int AIDS Soc; 2023 Oct 12; 26 Suppl 4(Suppl 4):e26149. PubMed ID: 37909174 [Abstract] [Full Text] [Related]
12. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero. Ajaykumar A, Zhu M, Kakkar F, Brophy J, Bitnun A, Alimenti A, Soudeyns H, Saberi S, Albert AYK, Money DM, Côté HCF, CIHR Team in Cellular Aging and HIV Comorbidities in Women and Children (Children and Women: AntiRetrovirals and Markers of Aging [CARMA]). J Infect Dis; 2021 Feb 24; 223(4):621-631. PubMed ID: 32638023 [Abstract] [Full Text] [Related]
13. 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission. Leroy V, Ekouevi DK, Becquet R, Viho I, Dequae-Merchadou L, Tonwe-Gold B, Rouet F, Sakarovitch C, Horo A, Timité-Konan M, Rouzioux C, Dabis F, ANRS 1201/1202 DITRAME PLUS Study Group. PLoS One; 2008 Feb 20; 3(2):e1645. PubMed ID: 18286200 [Abstract] [Full Text] [Related]
14. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, Hall DB, Robinson P, Mayers D, Martinson NA. PLoS Med; 2009 Oct 20; 6(10):e1000172. PubMed ID: 19859531 [Abstract] [Full Text] [Related]
15. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study. Williams PL, Yildirim C, Chadwick EG, Van Dyke RB, Smith R, Correia KF, DiPerna A, Seage GR, Hazra R, Crowell CS, Surveillance Monitoring for ART Toxicities (SMARTT) study of the Pediatric HIV/AIDS Cohort Study. Lancet HIV; 2020 Jan 20; 7(1):e49-e58. PubMed ID: 31740351 [Abstract] [Full Text] [Related]
19. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394 [Abstract] [Full Text] [Related]